{'fraction_non_alphanumeric': 0.011947431302270013, 'fraction_numerical': 0.0, 'mean_word_length': 5.813008130081301, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
STOOL TRANSPLANTATION FOR OLDER PATIENTS WITH CLOSTRIDIUM DIFFICILE INFECTION

DISCUSSION Short-term evidence-based CHF therapy in elderly patients with chronic cardiorenal syndrome was associated with improvement of clinical and hemodynamical parameters. At the same time, the therapy based on the renin-angiotensin-aldosterone system and sympatoadrenal system blockade was not associated with a significant decrease in kidney function in this group of patients with systolic CHF and moderate to severe renal insufficiency. Still, many questions on the care of elderly patients with heart failure and renal insufficiency remain unanswered. Future clinical trials in heart failure should include a representative number of elderly patients with renal insufficiency to improve the evidence base and outcomes in this vulnerable population.